Skip to main content
Veterinary Medicines

RILEXINE 200 MG/G ORAL PASTE

Not authorised
  • Cefalexin

Product identification

Medicine name:
RILEXINE 200 MG/G ORAL PASTE
RILEXINE, 200mg/g, Perorální pasta
Active substance:
  • Cefalexin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin
    200.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral paste
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01D
Authorisation status:
  • Surrendered
Authorised in:
  • Czechia
Package description:
  • Box with one aluminium sachet containing one graduated syringe of 21 g of oral paste (7 doses): each dose can treat 20 kg
  • Box with one aluminium sachet containing one graduated syringe of 10.5 g of oral paste (7 doses): each dose can treat 10 kg
  • Box with one aluminium sachet containing one graduated syringe of 4.2 g of oral paste (14 doses): each dose can treat 2 kg

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/012/05-C
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0127/001

Documents

Combined File of all Documents

English (PDF)
Published on: 15/02/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."